хочу придумать терапию для улучшения функционального состояния кожи людей среднего возраста до состояния молодых людей

Can skin heal without scarring or losing strength?

The question as the research states itAfter repeated skin injury, can protein suppression preserve strength and prevent scars, or do structures need conflicting schedules?

The whole reason

If this compatibility also held after repeated injury, reduced scarring could coexist with retained strength; if timing requirements conflicted, treating all skin structures during the same period could compromise some aspects of repair. Assuming compatibility from scar appearance alone would leave strength, sensation, sweating, and recovery after further injury unaccounted for.

The question in full

The question concerns whether the timing of suppressing Yes-associated protein (YAP), a protein involved in how cells respond to physical forces, can separate scar formation from the rebuilding needed for strong skin. It asks whether, after repeated injury, one treatment period can prevent scarring without reducing strength across the epidermis, the outer skin layer; the dermis, the supporting layer beneath it; and skin appendages, structures such as hair follicles and sweat glands. The decisive comparison is between a period compatible with all these structures and conflicting periods that protect one structure at another's expense. The question assumes that reducing force-related signals limits scarring, that insufficient YAP activity can impair repair, and that different skin structures recover on different schedules. Its broader functional targets include skin that returns to shape after deformation, sensation, sweating, and limited remaining stiffness, but the supplied material gives no numerical deadlines or acceptable limits.

Competing hypotheses

These hypotheses propose different mechanisms. Comparing their predictions helps identify observations that could distinguish them.

01Late Yes-associated protein activity may limit skin scarring by killing damaged repair cellsIn repeatedly injured, sun-damaged skin, a late pulse of Yes-associated protein (YAP) may trigger p73-dependent death of damaged myofibroblasts while preserving strength. Benefit persisting after verified YAP–p73 uncoupling would reject this mechanism.
02Less variable Yes-associated protein gene activation timing may widen safe suppression windowsAfter repeated skin injury, less variable timing of Yes-associated protein (YAP)-dependent gene activity may widen the suppression window that preserves strength, reversible deformation and barrier repair. A confirmed variability change without a window change would reject this as the determining mechanism.

Each entry represents a published hypothesis. Where no hypotheses are published yet, the entries show possible answers to the scientific question.

What results would tell us about the hypotheses

Choose a possible result to see which hypothesis it would support, what the alternatives predict, and what would need to be tested next.

If we observe

В модели повторного повреждения сравнивают непрерывное подавление YAP, временное подавление с обычной отменой и тот же режим с коротким поздним восстановлением активности YAP. Гипотеза предсказывает, что поздний импульс уменьшит остаточную контрактуру и рубцевание при сохранении разрывной прочности. Эффект должен сопровождаться апоптозом предварительно меченных повреждённых миофибробластов и исчезнуть при избирательном нарушении взаимодействия YAP–p73. При этом ранняя миграция, средняя активность YAP–TEAD и вариабельность транскрипционных ответов должны быть сопоставимы. Сохранение пользы импульса после подтверждённого разобщения YAP–p73 опровергнет предложенный механизм. Если вместо этого исход определяется разбросом транскрипционных задержек, преимущество получит Less variable Yes-associated protein gene activation timing may widen safe suppression windows. Hypothetical result

Would support the hypothesis

Late Yes-associated protein activity may limit skin scarring by killing damaged repair cells — In repeatedly injured, sun-damaged skin, a late pulse of Yes-associated protein (YAP) may trigger p73-dependent death of damaged myofibroblasts while preserving strength. Benefit persisting after verified YAP–p73 uncoupling would reject this mechanism.

Other hypotheses predict

Less variable Yes-associated protein gene activation timing may widen safe suppression windows — В одной серии моделей независимо изменяют начало подавления YAP и вариабельность транскрипционных ответов. Для сравнения подбирают режимы с одинаковыми средними уровнями ядерного YAP, средним выходом заранее выбранных восстановительных и профибротических генов, числом делений и исходным повреждением. Гипотеза предсказывает, что уменьшение разброса времени транскрипционных событий расширит диапазон начала подавления, при котором одновременно сохраняются прочность, обратимая деформация и восстановление барьера. Польза должна сохраняться при разобщении YAP–p73. Подтверждённое изменение вариабельности без изменения безопасного окна опровергнет её как определяющий механизм; специфическая зависимость результата от позднего YAP–p73-импульса поддержит Late Yes-associated protein activity may limit skin scarring by killing damaged repair cells.

What to check next

After repeated skin injury, is there a period of YAP suppression that reduces scarring while preserving strength and repair of the epidermis, dermis, and skin appendages?

These are hypothetical results. Selecting one shows what would follow from it; it does not confirm a hypothesis or change its assessment.

Comparing hypotheses

Compare the proposed mechanisms, the predictions that distinguish the hypotheses, and the observations that would count against each one.

Late Yes-associated protein activity may limit skin scarring by killing damaged repair cells

Damage coupled apoptotic termination

Proposed mechanism

In repeatedly injured, sun-damaged skin, a late pulse of Yes-associated protein (YAP) may trigger p73-dependent death of damaged myofibroblasts while preserving strength.

Full text

Проверяемая гипотеза: после повторных повреждений фотоповреждённой кожи завершение дермальной репарации требует короткого позднего импульса YAP, который через фосфорилирование по Tyr357 и связывание с транскрипционным фактором p73 запускает апоптоз повреждённых миофибробластов. Подавление YAP уменьшает раннее образование рубцовой ткани, но его продолжение через этот импульс сохраняет клетки, которые должны завершить своё участие в заживлении. Носитель незавершённого процесса представляет собой повреждённые миофибробласты с неисполненной программой апоптоза. Поэтому безопасный режим включает временное подавление с последующим восстановлением YAP-зависимого удаления этих клеток. Разобщение взаимодействий YAP с TEAD и p73 может позволить сохранить восстановление эпидермиса и придатков при прекращении фиброза. Устранение этого механизма должно стабилизировать SPV_3.

What distinguishes its prediction

Full text

Гипотеза предсказывает, что поздний импульс уменьшит остаточную контрактуру и рубцевание при сохранении разрывной прочности. Эффект должен сопровождаться апоптозом предварительно меченных повреждённых миофибробластов и исчезнуть при избирательном нарушении взаимодействия YAP–p73. При этом ранняя миграция, средняя активность YAP–TEAD и вариабельность транскрипционных ответов должны быть сопоставимы. Сохранение пользы импульса после подтверждённого разобщения YAP–p73 опровергнет предложенный механизм. Если вместо этого исход определяется разбросом транскрипционных задержек, преимущество получит IH_Q_L3_M_G4_2_02.

What would weaken the hypothesis

Less variable Yes-associated protein gene activation timing may widen safe suppression windows predicts instead: В одной серии моделей независимо изменяют начало подавления YAP и вариабельность транскрипционных ответов.

Full text

Для сравнения подбирают режимы с одинаковыми средними уровнями ядерного YAP, средним выходом заранее выбранных восстановительных и профибротических генов, числом делений и исходным повреждением. Гипотеза предсказывает, что уменьшение разброса времени транскрипционных событий расширит диапазон начала подавления, при котором одновременно сохраняются прочность, обратимая деформация и восстановление барьера. Польза должна сохраняться при разобщении YAP–p73. Подтверждённое изменение вариабельности без изменения безопасного окна опровергнет её как определяющий механизм; специфическая зависимость результата от позднего YAP–p73-импульса поддержит IH_Q_L3_M_G4_2_01.

Less variable Yes-associated protein gene activation timing may widen safe suppression windows

Stochastic transcriptional precision

Proposed mechanism

After repeated skin injury, less variable timing of Yes-associated protein (YAP)-dependent gene activity may widen the suppression window that preserves strength, reversible deformation and barrier repair.

Full text

Проверяемая гипотеза: совместимость сроков подавления YAP определяется разбросом времени исполнения YAP-зависимых программ в отдельных клетках. Последовательная сборка и разборка транскрипционных комплексов создаёт случайные задержки. После повторного повреждения распределение этих задержек расширяется: часть клеток ещё исполняет программу восстановления, когда другие уже длительно поддерживают профибротическую программу. Единый момент подавления тогда одновременно прерывает восстановление в запаздывающих клетках и слишком поздно останавливает рубцевание в опережающих. Причинный носитель представляет собой кинетику реакционных циклов и распределение транскрипционных событий. Гипотеза предсказывает, что снижение внутренней вариабельности при сохранении среднего ответа расширит общее безопасное окно без необходимости позднего YAP–p73-зависимого апоптоза. Это должно стабилизировать SPV_3 и согласованность этапов заживления SPV_4.

What distinguishes its prediction

В одной серии моделей независимо изменяют начало подавления YAP и вариабельность транскрипционных ответов.

Full text

What would weaken the hypothesis

Late Yes-associated protein activity may limit skin scarring by killing damaged repair cells predicts instead: В модели повторного повреждения сравнивают непрерывное подавление YAP, временное подавление с обычной отменой и тот же режим с коротким поздним восстановлением активности YAP.

Full text

No test is published for this question yet

The hypotheses above state the observations that could distinguish them. A proposed experiment for this question has not yet been published.

What to check next: After repeated skin injury, is there a period of YAP suppression that reduces scarring while preserving strength and repair of the epidermis, dermis, and skin appendages?

Every proposed test

What the literature settles, and what it does not

The sources read against this question, the assumption it rests on, and the verdict that follows.

After repeated skin injury, can protein suppression preserve strength and prevent scars, or do structures need conflicting schedules?

What this question is asking

What the terms mean

Yes-associated protein (YAP): A protein that helps regulate cellular responses, including responses to physical forces. Here it is the target of suppression; the supplied studies connect YAP-related activity with scar-forming repair in one setting and its inhibition with regeneration in another.
YAP suppression or inhibition: Reducing YAP activity. Drug treatment and genetic removal are different ways of doing this, and neither automatically establishes that suppression is temporary or equally strong in every skin structure.
Treatment window: A period after injury during which an intervention produces the desired combination of outcomes. A successful treatment at one time does not establish the earliest or latest effective time.
Mechanical activation, force-related signalling, or mechanotransduction: The process by which cells convert physical forces, such as stretching or tension, into biological signals. The question concerns whether reducing this process can limit scars while preserving repair.
Epidermis: The outer layer of skin. It is one of the structures whose repair timing the question asks to compare.
Dermis: The supporting skin layer beneath the epidermis. It contains cells and surrounding structural material involved in skin strength and scar formation.
Skin appendages: A collective name for structures associated with skin, including hair follicles and sweat glands. Recovery of appendages does not by itself demonstrate recovery of every type or of functions such as sweating.
Fibroblasts: Cells that produce and remodel much of the material supporting tissue. They are the cells in which YAP was specifically removed in one part of the mouse study.
Matrix: The material surrounding cells that provides structural support. Matrix degradation means breakdown of that material; the supplied sources do not establish the proposed connection between reduced tension and its degradation.
Collagen: A family of structural proteins in the material surrounding cells. Collagen contributes to tissue support and also accumulates during scar formation, so reduced accumulation alone does not establish preserved strength.
Fibrosis: Accumulation of fibrous supporting tissue, associated here with scarring. The supplied diabetic-mouse study reports that stimulating dermal fibrosis contributed to healing, illustrating why faster repair and less scarring are distinct outcomes.
Regeneration: Restoration of tissue structures following injury. The specific structures and functions recovered must be identified; the word alone does not establish complete restoration of skin function.
Mechanical strength: The ability of tissue to withstand physical force without failing. It differs from stiffness, which concerns resistance to deformation, and from the ability to return to shape afterward.
Verteporfin: A drug described in the supplied studies as an inhibitor of YAP. It was used to interfere with force-related signalling during wound repair.
Genetic removal: An alteration that eliminates a gene's function in the targeted cells. In the relevant mouse study, this targeted YAP in fibroblasts; it does not establish the effects of a reversible drug schedule throughout skin.
VT107: The compound tested in the preliminary scar-prevention study. The supplied abstract reports reduced scarring-related changes but does not establish a strength-preserving treatment period.
Growth differentiation factor 11 (GDF11): A signalling protein applied to skin wounds in the supplied diabetic-mouse study. Its reported healing effect involved increased dermal fibrosis through a pathway including YAP.
Diabetes: A group of conditions involving impaired regulation of blood sugar. It defines the disease setting of the GDF11 mouse study and limits direct comparison with other wound settings.

What the question takes for granted

Premise only partly supported

Suppressing mechanical activation reduces scarring, insufficient YAP activity impairs repair, reduced tension supports matrix degradation, and different skin structures recover asynchronously, creating potentially incompatible intervention periods.

The assumption concerns how physical forces and YAP influence repair in the skin's outer layer, supporting layer, and embedded structures such as glands. It proposes that reducing these signals limits scars but can also weaken rebuilding or encourage breakdown of the material surrounding cells, with each structure needing the signals at a different time. If established, this would explain why treatment timing could determine whether scar prevention preserves skin function.

Blocking force-related signalling involving YAP reduced scarring in mouse and pig wound studies, supporting that part of the premise [S5, S8]. However, the mouse study also reports recovery of mechanical strength and skin appendages under YAP inhibition, which limits any blanket claim that inhibition necessarily compromises repair [S5]. A separate study reports improved healing partly through increased scar-forming tissue production involving YAP, but this does not establish that insufficient YAP causes impaired repair [S1]. The supplied sources do not establish reduced tension causing breakdown of the surrounding tissue material, asynchronous recovery requiring different treatment periods, or incompatible timing after repeated injury. These unsupported parts remain unestablished rather than refuted.S1 S5 S8

The same question asked without the part nothing read establishes:

After repeated skin injury, is there a period of YAP suppression that reduces scarring while preserving strength and repair of the epidermis, dermis, and skin appendages?
After repeated skin injury, how do the effects of YAP suppression on scarring, strength, and repair of different skin structures depend on treatment timing?

What turns on the answer

A shared treatment period exists Suppressing YAP during that period would reduce scar formation while allowing the different skin structures to rebuild sufficiently to retain strength. This would establish compatibility for those outcomes after repeated injury, but would not by itself establish restored sensation or sweating.
Skin structures require conflicting periods A period that reduces scar formation in one structure would overlap with a period when another needs YAP activity for repair. Applying the same suppression schedule throughout the skin would therefore trade scar reduction against repair or strength in another structure.
No strength-preserving period is found Suppression might reduce scars only when strength is compromised, or it might fail to reduce scars after repeated injury. Either outcome would leave the desired combination unmet without establishing that conflicting schedules between structures caused the failure.

Why it matters

Repair must rebuild tissue that holds together under force while limiting the tissue changes that produce scars. One mouse study reports that blocking YAP-related signalling allowed recovery of skin structures and mechanical strength, so these outcomes were compatible in that setting [S5]. If this compatibility also held after repeated injury, reduced scarring could coexist with retained strength; if timing requirements conflicted, treating all skin structures during the same period could compromise some aspects of repair. Assuming compatibility from scar appearance alone would leave strength, sensation, sweating, and recovery after further injury unaccounted for.

Partly answered already

S5 settles a component of the question by reporting that YAP inhibition can coexist with regenerated skin structures and recovered mechanical strength in mouse wounds. S8 reports scar prevention and regeneration after immediate treatment in pigs, and S7 documents immediate treatment in mice. The inference from these findings is that scar prevention and repair are not necessarily incompatible. None of these sources establishes a treatment window after repeated injury or compares the timing requirements of the epidermis, dermis, and appendages, so the question's central timing fork remains unresolved.S5 S8 S7

What the literature establishes

In mouse wounds, blocking force-related signalling with verteporfin, described as a YAP inhibitor, or genetically removing YAP specifically from fibroblasts promoted regeneration with recovery of skin appendages, fine tissue structure, and mechanical strength [S5].S5
In pigs, one verteporfin treatment immediately after wounding was reported to prevent scarring and promote wound regeneration. The supplied evidence does not establish preserved mechanical strength in those pigs [S8].S8
A mouse wound study administered verteporfin immediately after injury, with a comparison group receiving an injection without the active drug. This documents a tested treatment time, not the range of times that would work [S7].S7
A preliminary study reports that the compound VT107 reduced scarring-related changes, including multiplication of fibroblasts and accumulation of collagen. Only its abstract was supplied as read material, and preservation of strength was not established [S2].S2
A study using daily treatment with a compound in male mice with wounds extending through the full skin thickness reports faster healing and less scar formation in the late healing phase. The supplied evidence does not establish a period of YAP suppression or the strength of the healed tissue [S3].S3
In mice with diabetes, applying growth differentiation factor 11 (GDF11) to skin wounds promoted healing partly by stimulating dermal fibrosis through a signalling pathway involving YAP. This finding was available only through the abstract [S1].S1
A review identifies wound models subjected to tension as important for studying how physical forces produce cellular signals, including signals involving YAP, that traditional unstressed models do not capture [S4].S4

What it does not settle

Whether YAP suppression after repeated skin injury can prevent scarring while preserving mechanical strength. The closest mouse evidence combines regeneration and recovered strength, but does not establish that combination after repeated injury [S5].S5
The start, duration, and end of any effective treatment period. Immediate treatment in mouse and pig wounds does not establish how much earlier or later suppression could work, or when YAP activity would need to return [S7, S8].S7 S8
Whether the epidermis, dermis, and skin appendages need overlapping or incompatible periods of YAP activity. Recovery of appendages in the mouse study does not establish separate timing requirements for these structures [S5].S5
Whether any reported treatment restores skin that returns to shape after deformation, sensation, sweating, or acceptable stiffness after repeated injury. The supplied input specifies neither numerical limits for these outcomes nor deadlines for their recovery.
Whether these findings apply to middle-aged human skin or restore function to a level characteristic of younger human skin. The closest supplied intervention evidence concerns mice and pigs [S5, S8].S5 S8

Where the sources disagree

There is a context-dependent tension: one study reports improved healing partly through increased dermal fibrosis involving YAP in diabetic mice, whereas another reports regeneration and recovered strength when YAP is inhibited in mouse wounds [S1, S5]. These are not direct opposing tests of the same treatment under the same conditions. They do prevent treating either increased fibrosis or YAP suppression as having one uniform relationship with successful repair.S1 S5

Sources read · 9

3 literature searches, 7 full texts, 3 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1BackgroundAbstract only

Topical GDF11 accelerates skin wound healing in both type 1 and 2 diabetic mouse models. · Biochemical and biophysical research communications · 2020

“Overall, the study shows that both natural and truncated GDF11s promote the healing process of skin wound in mice of both T1DM and T2DM partly via stimulating dermal fibrosis via the YAP-Smad2/3-CTGF pathway, suggesting it a potential agent for treating skin wound in diabetic population.”

Does not settle: Источник не исследует повторное повреждение, окно подавления YAP, рубцевание при сохранении прочности или различия во времени переключения между эпидермисом, дермой и придатками кожи.

S2Partly answers itAbstract only

Targeting TEAD would be a potential strategy for scarless wound repair: A preliminary study. · Acta histochemica · 2025

“Our findings confirmed VT107 exhibited favorable effect on preventing scarring, manifesting as reducing fibroblast proliferation and collagen denaturation, decreasing TGF-β1 and collagen deposition, as well as connective tissue growth factor (CTGF) expression.”

Does not settle: Источник не устанавливает эффект после повторного повреждения, временное окно подавления YAP, сохранение прочности ткани или согласованность моментов переключения в эпидермисе, дерме и придатках.

S3Partly answers it

CuATSM Enhances Wound Repair Without Scarring via Hippo/YAP Signalling Pathway to Reduce Ferroptosis and Macrophage Polarisation. · Journal of cellular and molecular medicine · 2025

“Our study reveals that CuATSM not only promotes rapid skin wound healing but also reduces scar formation in the late healing phase.”

Does not settle: Источник описывает ежедневное введение CuATSM в модели полнослойной кожной раны у самцов мышей. Он не устанавливает окно подавления YAP после повторного повреждения, прочность зажившей ткани, результаты у человека или необходимость разных моментов переключения для эпидермиса, дермы и придатков.

S4Background

Establishment and translational evaluation of animal models for skin wound healing: a systematic review. · Frontiers in physiology · 2026

“Pathological scarring: Tension-induced models (e.g., suture anchoring, mechanical stretching) are identified as critical for studying mechanotransduction pathways (e.g., YAP/TAZ) absent in traditional unstressed models.”

Does not settle: Источник не устанавливает, существует ли после повторного повреждения окно подавления YAP, его сроки, влияние на рубцевание и прочность, а также различаются ли требуемые моменты переключения в эпидермисе, дерме и придатках.

S5Partly answers it

Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring. · Science (New York, N.Y.) · 2021

“Finally, we showed that blocking mechanotransduction signaling with either verteporfin, an inhibitor of Yes-associated protein (YAP), or fibroblast-specific transgenic YAP knockout prevents Engrailed-1 activation and promotes wound regeneration by ENFs, with recovery of skin appendages, ultrastructure, and mechanical strength.”

Does not settle: Источник описывает заживление ран у мышей и подавление YAP в фибробластах. Он не устанавливает эффект после повторного повреждения, временное окно вмешательства и совместимость моментов переключения в эпидермисе, дерме и придатках.

S6Background

YAP/TAZ are crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis after bleomycin-induced injury. · The European respiratory journal · 2025

“Genetic inactivation of Yap/Taz resulted in a reduced population of Mo-AMs and IMs in bleomycin-treated lungs. This genetic alteration also led to a decrease in the expression of pro-inflammatory cytokines, chemokines and pro-fibrotic markers, culminating in reduced fibrosis in the lungs.”

Does not settle: Источник исследует лёгкие человека и мышей после блеомицинового повреждения, главным образом макрофаги. Он не устанавливает наличие окна подавления YAP после повторного повреждения кожи, его сроки, влияние на прочность ткани или совместимость моментов переключения в эпидермисе, дерме и придатках кожи.

S7Partly answers it

Multi-omic analysis reveals divergent molecular events in scarring and regenerative wound healing. · Cell stem cell · 2022

“Immediately after wounding, the wound bed was injected with verteporfin or vehicle (phosphate-buffered saline [PBS]) control.”

Does not settle: Источник описывает однократное немедленное подавление YAP в модели эксцизионной раны у мышей. Он не устанавливает окно после повторного повреждения, не сравнивает моменты переключения в эпидермисе, дерме и придатках и не определяет, совместимы ли такие моменты.

S8Partly answers it

Inhibiting mechanotransduction prevents scarring and yields regeneration in a large animal model. · Science translational medicine · 2025

“We show that one-time treatment with verteporfin, a YAP inhibitor, immediately after wounding is sufficient to prevent scarring and to drive wound regeneration in pigs.”

Does not settle: Источник не исследует повторное повреждение, временное окно подавления YAP после него, сохранение прочности кожи у свиней или необходимость разных моментов переключения в эпидермисе, дерме и придатках.

S10BackgroundAbstract only

Epidermolysis bullosa: a genetic disease of altered cell adhesion and wound healing, and the possible clinical utility of topically applied thymosin beta4. · Annals of the New York Academy of Sciences · 2007

“Inherited epidermolysis bullosa (EB), having an overall incidence of only about 19 in every 1 million live births, encompasses many phenotypically and genotypically distinct diseases characterized by the presence of recurrent blisters, mechanical fragility of the skin and other epithelial structures (most notably the cornea and gastrointestinal tract), and scar formation.”

Does not settle: Источник не изучает YAP, повторное повреждение как экспериментальную модель, окно его подавления, прочность ткани или раздельные сроки переключения в эпидермисе, дерме и придатках.

Every open question